Other clinical characteristics (white blood cell (WBC) count, hemoglobin, peripheral blood and bone marrow blasts, t-AML, and AML secondary to MDS/MPN) were not associated with RUNX1 mutational status. The gene discussed is RUNX1; the disease is myeloproliferative disorder.